This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 27/12/2684    most recent ATVBAHA.107.156257v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sukhanov, S. Articles by Delafontaine, P. Search for Related Content PubMed PubMed Citation Articles by Sukhanov, S. Articles by Delafontaine, P.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2684.)
© 2007 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

IGF-1 Reduces Inflammatory Responses, Suppresses Oxidative Stress, and Decreases Atherosclerosis Progression in ApoE-Deficient Mice

Sergiy Sukhanov; Yusuke Higashi; Shaw-Yung Shai; Charlotte Vaughn; Jessica Mohler; Yangxin Li; Yao-Hua Song; Jane Titterington; Patrick Delafontaine

From the Cardiology Section (S.S., Y.H., S.-Y.S., C.V., J.T., P.D.), Department of Medicine, Tulane University School of Medicine, New Orleans La; the School of Life Sciences (J.M.), Arizona State University, Tempe; the Laboratory of Heart Failure and Stem Cells (Y.L.), Texas Heart Institute, Houston; and the Department of Molecular Pathology (Y.-H.S.), University of Texas M.D. Anderson Cancer Center, Houston.

Correspondence to Patrick Delafontaine, Cardiology Section, Department of Medicine, Tulane University School of Medicine, 1430 Tulane Ave, SL-48, New Orleans, LA 70112. E-mail pdelafon{at}tulane.edu

Objective— Whereas growth factors, via their ability to stimulate vascular smooth muscle cell (VSMC) proliferation and migration, have been thought to play a permissive role in atherosclerosis initiation and progression, the role of insulin-like growth factor-1 (IGF-1) is unknown. Here we report for the first time that IGF-1 infusion decreased atherosclerotic plaque progression in ApoE-deficient mice on a Western diet.

Methods and Results— ApoE-null mice (8 weeks) were infused with vehicle or recombinant human IGF-1 and fed a high-fat diet for 12 weeks. Analysis of aortic sinuses revealed that IGF-1 infusion decreased atherosclerotic plaque progression and macrophage infiltration into lesions. Furthermore, IGF-1 decreased vascular expression of the proinflammatory cytokines interleukin-6 and tumor necrosis factor-, reduced aortic superoxide formation and urinary 8-isoprostane levels, and increased aortic pAkt and eNOS expression and circulating endothelial progenitor cells, consistent with an antiinflammatory, antioxidant, and prorepair effect on the vasculature.

Conclusions— Our data indicate that an increase in circulating IGF-1 reduces vascular inflammatory responses, systemic and vascular oxidant stress and decreases atherosclerotic plaque progression. These findings have major implications for the treatment of atherosclerosis.

Although insulin-like growth factor-1 (IGF-1) has been described to have pleiotropic effects in the vasculature, its role in the development and progression of atherosclerosis is obscure. Here we report that in ApoE-deficient mice fed a high-fat diet continuous infusion of IGF-1 suppressed progression of atherosclerosis potentially via antiinflammatory, antioxidant, and prorepair effects.

Key Words: insulin-like growth factor • atherosclerosis • apolipoprotein E • inflammatory response • oxidative stress

This article has been cited by other articles:

				D. M. Breen, K. K. Chan, J. K. Dhaliwall, M. R. Ward, N. Al Koudsi, L. Lam, M. De Souza, H. Ghanim, P. Dandona, D. J. Stewart, et al. Insulin Increases Reendothelialization and Inhibits Cell Migration and Neointimal Growth After Arterial Injury Arterioscler. Thromb. Vasc. Biol., July 1, 2009; 29(7): 1060 - 1066. [Abstract] [Full Text] [PDF]

				R. C. Kaplan, A. L. Fitzpatrick, M. N. Pollak, J. P. Gardner, N. S. Jenny, A. P. McGinn, L. H. Kuller, H. D. Strickler, M. Kimura, B. M. Psaty, et al. Insulin-Like Growth Factors and Leukocyte Telomere Length: The Cardiovascular Health Study J Gerontol A Biol Sci Med Sci, April 6, 2009; (2009) glp036v1. [Abstract] [Full Text] [PDF]

				N. Engberding, A. San Martin, A. Martin-Garrido, M. Koga, L. Pounkova, E. Lyons, B. Lassegue, and K. K. Griendling Insulin-Like Growth Factor-1 Receptor Expression Masks the Antiinflammatory and Glucose Uptake Capacity of Insulin in Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., March 1, 2009; 29(3): 408 - 415. [Abstract] [Full Text] [PDF]

				Y. Higashi, S. Sukhanov, S. Parthasarathy, and P. Delafontaine The ubiquitin ligase Nedd4 mediates oxidized low-density lipoprotein-induced downregulation of insulin-like growth factor-1 receptor Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1684 - H1689. [Abstract] [Full Text] [PDF]

				E. Succurro, F. Andreozzi, A. Sciaqua, M. L. Hribal, F. Perticone, and G. Sesti Reciprocal Association of Plasma IGF-1 and Interleukin-6 Levels With Cardiometabolic Risk Factors in Nondiabetic Subjects Diabetes Care, September 1, 2008; 31(9): 1886 - 1888. [Abstract] [Full Text] [PDF]

				D. Allard, N. Figg, M. R. Bennett, and T. D. Littlewood Akt Regulates the Survival of Vascular Smooth Muscle Cells via Inhibition of FoxO3a and GSK3 J. Biol. Chem., July 11, 2008; 283(28): 19739 - 19747. [Abstract] [Full Text] [PDF]